Jing L. Marantz insider trades: Scholar Rock Holding (SRRK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jing reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | SRRK | ↓ Sell | 4,157 | $46.53 | $193K | Direct | Feb 19, 2026 (2d) |
| Jan 16, 2026 | SRRK | ↓ Sell | 5,798 | $44.48 | $258K | Direct | Jan 21, 2026 (5d) |
| Jan 16, 2025 | SRRK | ↓ Sell | 5,655 | $44.20 | $250K | Direct | Jan 21, 2025 (5d) |
| Nov 25, 2024 | SRRK | ↓ Sell | 8,520 | $37.06 | $316K | Direct | Nov 26, 2024 (1d) |
| Nov 11, 2024 | SRRK | ↓ Sell | 2,105 | $30.00 | $63K | Direct | Nov 13, 2024 (2d) |
| Oct 7, 2024 | SRRK | ↓ Sell | 109,375 | $27.21 | $3.0M | Direct | Oct 7, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SRRK insiders
Open-market trades in the last 12 months
About Jing L. Marantz's insider trades
Jing L. Marantz is Chief Medical Officer at Scholar Rock Holding (SRRK). Since Oct 7, 2024, Jing has reported no open-market purchases and 6 sales worth $4.1M on SEC Form 4. In the last 12 months: 2 sales ($451K).
Their filings also include grants and awards (14 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SRRK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.